Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 08 - 01 tags : Application save search
Krystal Biotech Receives FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial
Published: 2022-08-01 (Crawled : 23:00) - biospace.com/
KRYS | $164.04 -3.3% -3.41% 280K
|
Health Technology
|
| O: 1.35%
H: 0.19%
C: -5.15%
kb407 fda fibrosis biotech application trial cystic fibrosis
Krystal Biotech Announces FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial
Published: 2022-08-01 (Crawled : 23:00) - globenewswire.com
KRYS | $164.04 -3.3% -3.41% 280K
|
Health Technology
|
| O: -0.8%
H: 5.03%
C: 4.05%
kb407 fda fibrosis biotech application trial cystic fibrosis
What’s New: Automation Actions in the PagerDuty Application for Zendesk by Carrie Lacina
Published: 2022-08-01 (Crawled : 21:00) - pagerduty.com
PD | News | $20.83 -1.84% 0.0% 1.3M
|
Technology Services
|
| O: -1.85%
H: 4.26%
C: 3.14%
pagerduty application
What’s New: Automation Actions in the PagerDuty Application in Zendesk by Carrie Lacina
Published: 2022-08-01 (Crawled : 20:00) - pagerduty.com
PD | News | $20.83 -1.84% 0.0% 1.3M
|
Technology Services
|
| O: -1.85%
H: 4.26%
C: 3.14%
pagerduty application
SCYNEXIS Announces U.S. Food and Drug Administration Acceptance and Priority Review of the Supplemental New Drug Application for BREXAFEMME®
Published: 2022-08-01 (Crawled : 13:00) - biospace.com/
SCYX | $1.47 3.52% 3.4% 80K
|
Health Technology
|
| O: -0.43%
H: 6.09%
C: 5.22%
brexafemme drug application review food
SCYNEXIS Announces U.S. Food and Drug Administration Acceptance and Priority Review of the Supplemental New Drug Application for BREXAFEMME® (ibrexafungerp tablets) for Prevention of Recurrent Vaginal Yeast Infections
Published: 2022-08-01 (Crawled : 13:00) - globenewswire.com
SCYX | $1.47 3.52% 3.4% 80K
|
Health Technology
|
| O: -0.43%
H: 6.09%
C: 5.22%
brexafemme drug application infections review food
Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application
Published: 2022-08-01 (Crawled : 11:00) - globenewswire.com
BEAM | $24.33 0.08% 0.08% 1.7M
|
Health Technology
|
| O: -8.88%
H: 8.29%
C: 2.53%
beam-201 fda application therapeutics clinical hold
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart for the Prevention of Rejection in Kidney Transplant Recipients
Published: 2022-08-01 (Crawled : 10:00) - biospace.com/
ELDN | $1.99 26.75% 21.11% 310K
|
Manufacturing
|
| O: 3.32%
H: 1.61%
C: -2.57%
fda clearance kidney application
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.